Latest Conference Articles

ACP 2025. A focused CRC prevention program begins with primary care where support and advocacy for regular screening begins, Issaka stressed.

ACP 2025: Issaka, from the Fred Hutchinson Cancer Center, told internists that three-quarters of CRC deaths can be attributed to 3 types of screening failure.

AAAAI 2025: RSV vaccine and immunoprophylaxis uptake remained low in 2024 across infants, pregnant individuals, and older adults.

ACP 2025: Kim Sandler, MD, outlines key strategies to boost lung cancer screening uptake in primary care.

ACP 2025. The director of the UCSF Headache Center built an evidence-based framework for diagnosing and treating headache disorders seen in primary care.

ACP 2025: Laura Davisson, MD, outlines how PCPs can navigate GLP-1 medication coverage issues and why to consider recent cash-pay options.

ACP 2025: Dr Press explains how primary care clinicians can implement the collaborative care model to integrate mental health services, improve outcomes, and navigate reimbursement.

ACP 2025. Karol E Watson, MD, PhD, highlighted how traditional approaches to CV care have poorly addressed the unique presentations, risk factors, and pathophysiology of heart disease in women.

ACP 2025. Harvard gerontologist and preventive cardiologist Ariela Orkaby, MD, MPH, highlighted the many nuances required in the cardiovascular care of the aging population.

ACP 2025: Kim Sandler, MD, explains how primary care physicians can use shared decision-making to guide patients through lung cancer screening, emphasizing risk, benefit, follow-up, and smoking cessation.

ACP 2025: Kim Sandler, MD, sat down with Patient Care to discuss the benefits of lung cancer screening, citing a 20% reduction in lung cancer mortality with annual screenings.

ACP 2025. Scripps Clinic's John M Kelso, MD, offered topline updates on all types of allergies including a step-by-step on how to "delabel" patients identified as penicillin-allergic.

Foluso A. Fakorede, MD, sketched a disturbing picture of recognition and management of PAD in the US, highlighting stark racial and ethnic disparities and making an urgent call to action.

The highest CRC mortality rates occur at the “intersection of race, place, and class," Rachel Issaka, MD, MAS, told internal medicine clinicians at the annual ACP meeting.

Breaking research presented at ACP Internal Medicine 2025 showed that switching GLP1-RAs resulted in better glucose and weight control among adults with inadequately controlled T2D.

ACP 2025: Kim Sandler, MD, discussed the latest screening guidelines, real-world challenges in implementation, and the essential role of shared decision-making.

Dagogo-Jack reviewed alarming data on the damage prediabetes can inflict even decades before a diabetes diagnosis and offered guidance to the internal medicine audience.

William Lewis, MD, discussed the importance of photo-documentation, referral indicators, efficacy of various treatments, and other topics.

ACP 2025. A quick look at 2 topics in dermatology rounded out a Multiple Small Feedings of the Mind session at the 2025 American College of Physicians annual meeting.

ACP 2025. Ruth Etzioni, PhD, discussed evidence-based approaches to screening for patients at average risk, start and stop criteria, MRI for follow-up screening, and other topics.

In a new position paper, the ACP calls for policy action to address rural health disparities, improve access to care, and strengthen the rural health care workforce.

ACP 2025: Irl B Hirsch, MD, reviewed findings from 8 papers published in 2024 that he believes have made or will make a difference in the practice or understanding of the clinical area.

ACP 2025. Thomas Martens, MD, Gregg Simonson, PhD, and Libby Johnson, RDN, LD, CDCES explained the benefits of CGM, how to interpret data, and then adjust treatment accordingly.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

Your daily dose of the clinical news you may have missed.

For the same level of baseline health, the increase in risk related to each of 8 key CV risk factors appears significantly higher in women than in men.

AAD 2025: Raj Chovatiya, MD, PhD, MSCI, well-known physician scientist, says underrepresentation in clinical trials of those with skin of color precludes an evidence-based answer.

Raj Chovatiya, MD, PhD, MSCI, discusses the complex and widely variable influences that affect the manifestations and burden of atopic dermatitis across populations.

AAD 2025: Chovatiya discusses whether melanin concentration plays a role in skin physiology and cautioned against typing with factors that are not true biologic constructs.